COMMUNIQUÉS West-GlobeNewswire
-
LIXTE Biotechnology Holdings to Present at Two Investor Conferences
15/08/2024 - 14:30 -
Pathos Expands Pipeline With Worldwide License of Phase 2-ready Brain-penetrant, PRMT5 Inhibitor
15/08/2024 - 14:00 -
DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
15/08/2024 - 14:00 -
Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma
15/08/2024 - 14:00 -
Empower: Discover the Future of Healthcare at Inovalon’s Annual Data-Driven Summit
15/08/2024 - 14:00 -
Noah Medical Shares Diagnostic Confidence of its Galaxy Users at AABIP 2024
15/08/2024 - 14:00 -
Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer
15/08/2024 - 14:00 -
Lifeward Reports Second Quarter 2024 Financial Results
15/08/2024 - 14:00 -
Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer
15/08/2024 - 14:00 -
Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform
15/08/2024 - 14:00 -
SciSparc Updates Regarding the Status of the AutoMax Merger
14/08/2024 - 22:53 -
Yield10 Bioscience Announces Second Quarter 2024 Financial Results
14/08/2024 - 22:37 -
HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights
14/08/2024 - 22:35 -
Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
14/08/2024 - 22:30 -
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update
14/08/2024 - 22:30 -
Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET
14/08/2024 - 22:30 -
Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity
14/08/2024 - 22:25 -
PetVivo Reports Reports Fiscal Q1 2025 Results
14/08/2024 - 22:25 -
NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million
14/08/2024 - 22:25
Pages